Tech Company Financing Transactions

OWKIN Funding Round

Private investors invested in a $35.9 million funding round for OWKIN. The financing round was announced on 3/31/2023.

Transaction Overview

Company Name
Announced On
3/31/2023
Transaction Type
Venture Equity
Amount
$35,863,000
Round
Undisclosed
Investors
Proceeds Purpose
This project will make it possible to better fight cancer by equipping healthcare professionals with innovative artificial intelligence tools. The aim is to help doctors make the best use of the information contained in histological slides to personalise treatments. This ambitious project brings together major players in the field, both public and private, to form a community of internationally recognised and complementary experts. Nearly 15 million euros from France 2030 have been allocated to this project.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
831 Bdwy. 3R
New York, NY 10003
USA
Phone
Undisclosed
Email Address
Overview
OWKIN adresses the problem of low efficiency of pharma R&D in cancer and chronic diseases. Developing new integrative and interpretable technologies of machine learning, OWKINpharma main program harnesses pharmaceutical data such as chemical or clinical trials measurements.
Profile
OWKIN LinkedIn Company Profile
Social Media
OWKIN Company Twitter Account
Company News
OWKIN News
Facebook
OWKIN on Facebook
YouTube
OWKIN on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Clozel
  Thomas Clozel LinkedIn Profile  Thomas Clozel Twitter Account  Thomas Clozel News  Thomas Clozel on Facebook
Chief Operating Officer
Anna Bondarenko
  Anna Bondarenko LinkedIn Profile  Anna Bondarenko Twitter Account  Anna Bondarenko News  Anna Bondarenko on Facebook
Chief Scientific Officer
Gilles Wainrib
  Gilles Wainrib LinkedIn Profile  Gilles Wainrib Twitter Account  Gilles Wainrib News  Gilles Wainrib on Facebook
Chief Technical Officer
Pierre Courtiol
  Pierre Courtiol LinkedIn Profile  Pierre Courtiol Twitter Account  Pierre Courtiol News  Pierre Courtiol on Facebook
VP - Bus. Development
Anna Huyghues-Despointes
  Anna Huyghues-Despointes LinkedIn Profile  Anna Huyghues-Despointes Twitter Account  Anna Huyghues-Despointes News  Anna Huyghues-Despointes on Facebook
VP - Engineering
Camille Marini
  Camille Marini LinkedIn Profile  Camille Marini Twitter Account  Camille Marini News  Camille Marini on Facebook
VP - Finance
Isabelle Laforgue
  Isabelle Laforgue LinkedIn Profile  Isabelle Laforgue Twitter Account  Isabelle Laforgue News  Isabelle Laforgue on Facebook
VP - Product Management
Mathieu Galtier
  Mathieu Galtier LinkedIn Profile  Mathieu Galtier Twitter Account  Mathieu Galtier News  Mathieu Galtier on Facebook
VP - R & D
Mikhail Zaslavskiy
  Mikhail Zaslavskiy LinkedIn Profile  Mikhail Zaslavskiy Twitter Account  Mikhail Zaslavskiy News  Mikhail Zaslavskiy on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2023: Iteration X venture capital transaction
Next: 3/31/2023: PxE Holographic Imaging venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary